← Leaderboards
Renda Soylemez Wiener
Va Boston Health Care System
$1,542,263
Attributed
$2,906,954
Total exposure
9
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $835.3K · FY2009–25$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,906,954 · 2
VA$0 · 7
By mechanism
K12$2,047,036 · 1
K07$859,918 · 1
I01$0 · 5
I21$0 · 2
Top collaborators
- Stephenie C. Lemon3 shared
- Peter Kyle Lindenauer3 shared
- Amy Linsky3 shared
- Tanner J Caverly1 shared
- Guneet Jasuja1 shared
- Donald Keith Mcinnes1 shared
- Nichole Tripician Tanner1 shared
Most similar at Va Boston Health Care System
Same institution · by research overlap
- Amy Linsky$0
- Jason L Vassy$2,747,135
- Jennifer R Fonda$0
Others in their field
Top investigators on “Learning”
- Praduman Jain · Vignet, Inc.$145,457,385
- Robert B Gagosian · Consortium For Ocean Leadership, Inc$140,113,248
- Greg Ulses · Consortium For Ocean Leadership, Inc$140,113,248
- Mary L. Disis · University Of Washington$129,059,152
- Lee Marshall Nadler · Dana-Farber Cancer Inst$124,071,843
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$115,886,990
Research focus
LearningSiteVeteransAffectGuidelinesProgramsCaringDesignVariantFutureInterviewCessation Of LifeTrainingDecision MakingHealthcareMalignant Neoplasm Of LungShared Decision MakingRecommendationEvaluationPreferenceProviderBaseAmericanAged
Grant awards (27)
Co-Design and Pilot Testing of Peer-led Community Outreach to Improve Equity, Veteran-Centeredness and Uptake of Lung Cancer Screening$0
I21 · FY2025 · VA · contact PI
Prediction Augmented Screening Initiative$0
I01 · FY2025 · VA
CHOIR Summer Research Program (CHOIR-SRP)$0
I01 · FY2025 · VA
Impact of COVID-19 on implementation and outcomes of VA's Life-Sustaining TreatmentDecisions Initiative$0
I01 · FY2024 · VA
Co-Design and Pilot Testing of Peer-led Community Outreach to Improve Equity, Veteran-Centeredness and Uptake of Lung Cancer Screening$0
I21 · FY2024 · VA · contact PI
Impact of COVID-19 on implementation and outcomes of VA's Life-Sustaining TreatmentDecisions Initiative$0
I01 · FY2024 · VA
Impact of COVID-19 on implementation and outcomes of VA's Life-Sustaining TreatmentDecisions Initiative$0
I01 · FY2022 · VA
K12 Cardiopulmonary Implementation Science Scholars Program$386,120
K12 · FY2021 · HL
Factors and Outcomes Associated with Inappropriate Prescribing of Phosphodiesterase-5-Inhibitors for Pulmonary Hypertension$0
I01 · FY2021 · VA · contact PI
Factors and Outcomes Associated with Inappropriate Prescribing of Phosphodiesterase-5-Inhibitors for Pulmonary Hypertension$0
I01 · FY2021 · VA · contact PI
Achieving appropriate, safe, and patient-centered lung cancer screening$0
I01 · FY2021 · VA · contact PI
Factors and Outcomes Associated with Inappropriate Prescribing of Phosphodiesterase-5-Inhibitors for Pulmonary Hypertension$0
I01 · FY2021 · VA · contact PI
K12 Cardiopulmonary Implementation Science Scholars Program$825,598
K12 · FY2020 · HL
Achieving appropriate, safe, and patient-centered lung cancer screening$0
I01 · FY2020 · VA · contact PI
Achieving appropriate, safe, and patient-centered lung cancer screening$0
I01 · FY2020 · VA · contact PI
K12 Cardiopulmonary Implementation Science Scholars Program$835,318
K12 · FY2019 · HL
Factors and Outcomes Associated with Inappropriate Prescribing of Phosphodiesterase-5-Inhibitors for Pulmonary Hypertension$0
I01 · FY2019 · VA · contact PI
Factors and Outcomes Associated with Inappropriate Prescribing of Phosphodiesterase-5-Inhibitors for Pulmonary Hypertension$0
I01 · FY2019 · VA · contact PI
Achieving appropriate, safe, and patient-centered lung cancer screening$0
I01 · FY2019 · VA · contact PI
Factors and Outcomes Associated with Inappropriate Prescribing of Phosphodiesterase-5-Inhibitors for Pulmonary Hypertension$0
I01 · FY2019 · VA · contact PI
Progressing towards implementation of lung cancer screening in the VHA$0
I21 · FY2015 · VA · contact PI
Improving decisions about evaluating pulmonary nodules for lung cancer$169,236
K07 · FY2013 · CA · contact PI
Improving decisions about evaluating pulmonary nodules for lung cancer$169,236
K07 · FY2012 · CA · contact PI
Improving decisions about evaluating pulmonary nodules for lung cancer$169,236
K07 · FY2011 · CA · contact PI
Improving decisions about evaluating pulmonary nodules for lung cancer$169,236
K07 · FY2010 · CA · contact PI
Improving decisions about evaluating pulmonary nodules for lung cancer$169,027
K07 · FY2009 · CA · contact PI
Improving decisions about evaluating pulmonary nodules for lung cancer$13,947
K07 · FY2009 · CA · contact PI